“Moving to the Cambridge Biomedical Campus means our people will be able to rub shoulders with some of the world’s best scientists and clinicians carrying out some of the world’s leading research – that’s a really exciting prospect. We hope that our move will contribute to the growing success of Cambridge”.
Pascal Soriot, Chief Executive Officer – AstraZeneca
If you are involved in innovative biomedical research or you supply products and services for biomedical research, we invite you to locate your business on the Cambridge Biomedical Campus, either in bespoke single-occupier or multi-occupancy laboratories and offices or in 1000 Discovery Drive, a speculative, five storey combination of laboratory and office space, granted planning permission in February 2021.
With the first phase of the campus expansion fully allocated, developers Liberty Property Trust and Countryside are now focused on Phase 2. The masterplan for this additional 14 acres, which is based on generous open spaces, landscaped boulevards and cycle-ways, is designed to accommodate up to 75,000 sq m (807,300 sf) of floorspace. 1000 Discovery Drive will be a multi-occupancy building combining B1(b) laboratory and Cat A, BCO compliant office uses with opportunities for collaboration. The building has been designed to provide flexible laboratory (wet and or dry) and office (50:50) space, for businesses involved in life sciences R&D.
It can accommodate occupation on a floor-by-floor basis and multiple tenants per floor (4 max) – each floor approximately 1,858 sq m (20,000 sq ft) NIA. It will have a striking external appearance, with a compelling entrance attraction.
An abstract ‘tree’ structure that symbolises the connection between structure, building and science, celebrates arriving at this centre for collaboration and innovation.
Alongside a double height reception, a contemporary café space will spill out onto the plaza and meeting rooms will be provided for all occupants with the vibrant buzz of shared social spaces.
The Biomedical Campus offers so much more than conventional science parks. It is a highly networked community of Academics, Businesses and Clinicians [A, B, C] who are committed to working together to bring new and improved products and services to patients; an environment where companies can research and develop products in partnership with clinicians; where products can be transitioned from the laboratory to the clinic on the same site; and where businesses can communicate, person-to-person, with key opinion leaders both from academia and the NHS.
The existing occupiers comprising healthcare professionals and research scientists at Cambridge University Hospitals NHS Foundation Trust, Cancer Research UK Cambridge Institute, the Medical Research Council Laboratory of Molecular Biology and the University of Cambridge School of Clinical Medicine are open to working alongside companies that can add value to the world-class research, education and clinical practice already taking place on the Biomedical Campus.
In addition to Phase 2, the other new buildings on-site include/proposed:
- AstraZeneca – Strategic R&D Centre and Corporate HQ – due to open in 2021
- Royal Papworth Hospital – a 310-bed purpose-built heart and lung hospital – opened 2019
- Heart and Lung Research Institute – under construction, scheduled to complete in 2022
- The Jeffrey Cheah Biomedical Centre for the University of Cambridge opened in 2019
- The Anne McLaren building for the University of Cambridge opened in 2020
- 1000 Discovery Drive – 9569 sq m (103,000 sf) speculative, 5 storey, laboratory and office, for multi-occupancy, granted planning 2021
- Cambridge Children’s Hospital – due to open in 2025
- Cambridge Cancer Hospital – due to open in 2025
AstraZeneca has officially opened The Discovery Centre (DISC) in Cambridge – a state-of-the-art research and development facility designed to the world’s highest environmental standards and accommodating over 2,200 research scientists. The new £1bn facility will...
Liberty Property Trust, a Prologis company, and Countryside Properties, the developers of the hugely successful Cambridge Biomedical Campus expansion, have been granted planning consent for 1000 Discovery Drive. The building, designed to be multi-let from the...
Network Rail is launching a public consultation in January 2020 on proposals for a new railway station and associated infrastructure in the south of Cambridge. The public will be invited to attend consultation events to comment on the proposals being put forward which...
Amazing things happen on the campus every day from lifesaving operations to breakthroughs in research. People here are dedicated to making a difference and in order for them to succeed we need to look after them and the patients they help. This means making the site a...
Interested in joining UKSPA?
Gain exclusive access to members only resources, research papers, statistics and data – as well as discounted or even free entry to the conferences and events we hold through the year.